---
$id: https://graph.org.ai/products/commodity/51131734
$type: Product
source: UNSPSC
code: "51131734"
title: "Nicogrelate"
class: "51131700"
classTitle: "Thrombolytic drugs and platelet aggregation inhibitors"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Nicogrelate

**UNSPSC Code**: 51131734
**Class**: [Thrombolytic drugs and platelet aggregation inhibitors](Thrombolytic drugs and platelet aggregation inhibitors.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiplatelet agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DW310SVK6Q. European Medicines Agency schedules Nicogrelate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09239MIG. Nicogrelate generally arises in the molecular formula C17H21N3O2. The term NICOGRELATE is an International Non-Proprietary Name or INN. NICOGRELATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nicogrelate under HS 29333999 and SITC 51574. As of Q4 2014, NICOGRELATE remains the US FDA Preferred Term for this commodity. Nicogrelate bears US NLM identifiers UMLS ID C2698462 and NCI Concept Code C76399. SMILES: O(C(CCCCC)/C=C/N1CCNC1)C(=O)C1CCCNC1.

